ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for monitor Customisable watchlists with full streaming quotes from leading exchanges, such as LSE, NASDAQ, NYSE, AMEX, Bovespa, BIT and more.

CYDY CytoDyn Inc (QB)

0.1382
-0.0048 (-3.36%)
29 Apr 2024 - Closed
Delayed by 15 minutes
Share Name Share Symbol Market Type
CytoDyn Inc (QB) USOTC:CYDY OTCMarkets Common Stock
  Price Change % Change Share Price Bid Price Offer Price High Price Low Price Open Price Shares Traded Last Trade
  -0.0048 -3.36% 0.1382 0.138 0.15 0.142 0.135 0.135 563,115 21:30:15

Initial Statement of Beneficial Ownership (3)

18/03/2021 11:46pm

Edgar (US Regulatory)


FORM 3
        
UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

INITIAL STATEMENT OF BENEFICIAL OWNERSHIP OF SECURITIES

OMB APPROVAL
OMB Number: 3235-0104
Estimated average burden
hours per response...
0.5
                      
Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934 or Section 30(h) of the Investment Company Act of 1940
                      

1. Name and Address of Reporting Person *

Recknor Chris P
2. Date of Event Requiring Statement (MM/DD/YYYY)
3/11/2021 

3. Issuer Name and Ticker or Trading Symbol

CytoDyn Inc. [CYDY]
(Last)        (First)        (Middle)

1111 MAIN STREET, SUITE 660
4. Relationship of Reporting Person(s) to Issuer (Check all applicable)

_____ Director                          _____ 10% Owner
___X___ Officer (give title below)        _____ Other (specify below)
Chief Operating Officer /
(Street)

VANCOUVER, WA 98660      

(City)              (State)              (Zip)
5. If Amendment, Date Original Filed(MM/DD/YYYY)
 

6. Individual or Joint/Group Filing(Check Applicable Line)

_X_ Form filed by One Reporting Person
___ Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Beneficially Owned
1.Title of Security
(Instr. 4)
2. Amount of Securities Beneficially Owned
(Instr. 4)
3. Ownership Form: Direct (D) or Indirect (I)
(Instr. 5)
4. Nature of Indirect Beneficial Ownership
(Instr. 5)
Common Stock 666666 D  

Table II - Derivative Securities Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivate Security
(Instr. 4)
2. Date Exercisable and Expiration Date
(MM/DD/YYYY)
3. Title and Amount of Securities Underlying Derivative Security
(Instr. 4)
4. Conversion or Exercise Price of Derivative Security5. Ownership Form of Derivative Security: Direct (D) or Indirect (I)
(Instr. 5)
6. Nature of Indirect Beneficial Ownership
(Instr. 5)
Date ExercisableExpiration DateTitleAmount or Number of Shares
Non-qualified Stock Option (right to buy) 6/10/2020 6/10/2025 Common Stock 50000 $6.15 D  
Non-qualified Stock Option (right to buy)  (1)8/27/2030 Common Stock 200000 $3.15 D  

Explanation of Responses:
(1) Non-qualified stock option vests in three equal annual installments beginning on August 27, 2021.

Reporting Owners
Reporting Owner Name / Address
Relationships
Director10% OwnerOfficerOther
Recknor Chris P
1111 MAIN STREET
SUITE 660
VANCOUVER, WA 98660


Chief Operating Officer

Signatures
Arian Colachis, Attorney-in-fact3/18/2020
**Signature of Reporting PersonDate

1 Year CytoDyn (QB) Chart

1 Year CytoDyn (QB) Chart

1 Month CytoDyn (QB) Chart

1 Month CytoDyn (QB) Chart

Your Recent History

Delayed Upgrade Clock